News
On Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, ...
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...
A recall of potato chips due to the possible presence of an undeclared allergen has been issued the second-highest risk warning by the U.S. Food and Drug Administration ( FDA ). Saratoga Potato Chips ...
By Stephanie Brown HealthDay ReporterTUESDAY, July 15, 2025 (HealthDay News) -- The U.S Food and Drug Administration has ...
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
After state lawmakers outlawed the fluoridation of communities' waters, a Utah dentist is testifying to the FDA to encourage ...
The FDA told Whoop that its Blood Pressure Insights feature (available only on the Whoop MG with the top-tier Life membership ...
The U.S. Food and Drug Administration's staff reviewers on Wednesday raised efficacy concerns over Otsuka Pharma's combination treatment for adults with post-traumatic stress disorder (PTSD), citing ...
The agency claims Whoop is marketing an unauthorized medical device intended to diagnose, cure, treat or prevent a disease.
The FDA is reevaluating GlaxoSmithKline’s blood cancer drug Blenrep following mixed results from two phase 3 trials and mounting concerns about eye-related side effects and dosing. The agency is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results